| Name | Title | Contact Details |
|---|
CarbonBuilts Carbon XPrize-winning technology enables the production of ultra low-carbon concrete products, driving gigatonne-scale greenhouse gas reductions through the cost-effective mineralization of carbon dioxide. Our revolutionary approach reduces overall carbon dioxide emissions by 70-100%+, with no compromise on price, performance, or plant operations.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The founder of Conval, Chester A. Siver, developed an innovative and technologically advanced line of forged steel globe valves for high pressure and high temperature steam service applications primarily for the power generation industry. In 1967, Conval was incorporated and manufacturing facilities were established in Somers, Connecticut. Conval has developed extensions to the original product line which include: • "T" and angle pattern bodies • 3500 pound and a 4500 pound series • 2 1/2, 3, and 4 inch sizes • Bellows seal valves • 3 way valves • A variety of material options • Cryogenic valves • Multiple orifice blowdown valves • Ball Valves • Nuclear Power Plant Valves Convals provides basic valve products that are durable, maintainable, and yield a low cost solution over the serviceable life of the valve. Markets for Conval include the power generation industry, refining, oil and gas production, chemical, fertilizer, and pulp industries. Besides the domestic United States market, other projected growth markets are Canada, Australia, China, Southeast Asia, Mexico, South America, and developing third world countries. Over one half of Convals sales are made internationally. Conval became a Certified ISO 9001 manufacturer in September 1992. BVQI (Bureau Veritas Quality International, N.A., Inc.) semi-annually certifies that Convals Quality Management System is in accordance with appropriate international standards for design, development, production, installation, and servicing. Also, Convals quality program meets the requirements of 10CFR50, Appendix B of the Code of Federal Regulations and ASME N Stamp for its nuclear customers, and the European Pressure Equipment Directive. Conval employs approximately 100 employees working on two shifts. Convals operations consist of the machining of most parts used to assemble finished valves, the maintenance of adequate parts inventory to support production, and the development of new valve products.
U.S. Figure Skating is the national governing body for figure skating in the United States, established in 1921. Based in Colorado Springs, Colorado, it is recognized by the United States Olympic & Paralympic Committee and is a member of the International Skating Union. The organization promotes figure skating through various services and programs. U.S. Figure Skating offers competitive pathways for skaters, including testing and competition opportunities that lead to World and Olympic events. The "Learn to Skate USA" program supports both recreational and competitive skaters, with over 1,000 active programs across 49 states. The organization also provides resources for member clubs and offers volunteer opportunities in roles such as judging and officiating. Additionally, it sanctions competitions and provides educational materials for coaches and skaters. The organization serves a diverse customer base, including over 750 member clubs, individual skaters, and supporters of figure skating. U.S. Figure Skating is also home to the World Figure Skating Museum and Hall of Fame, attracting thousands of visitors each year.